Kedar Kirtane, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Travel
    Ineligible company: 
    A2Bio Therapeutics
    Topic: 
    CAR-T for Solid Tumors
    Date added: 
    05/04/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Seattle Genetics
    Date added: 
    05/04/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Oncternal Therapeutics
    Date added: 
    05/04/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Shockwave Medical
    Date added: 
    05/04/2023
Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes